Stony Brook Urology's Prostate Cancer Program offers free screenings throughout the year at various locations across Suffolk County.
Stony Brook Medicine's Department of Urology has a long-standing commitment to providing free prostate cancer screenings for at-risk individuals. The Prostate Cancer Program team has been recognized for their efforts by New York State Senators John Flanagan, Kenneth Lavalle, and the New York State Assembly.
Our Next Free Prostate Cancer Screening:
|
Wednesday, September 25th, 2024 No insurance required. |
CLICK HERE to access our screening form to print, complete, and bring with you to the screening.
Para Español: Click here
Screening Eligibility
Stony Brook Medicine’s Department of Urology and Stony Brook Cancer Center, in accordance with the National Comprehensive Cancer Network guidelines, recommend screenings for:
- Men 45-75 years of age who are at average risk of developing prostate cancer.
- Men 40-75 years of age who are at high risk of developing prostate cancer.
African American men and men with a family history of prostate cancer are considered to be at higher risk.
Participants must meet our guidelines in order to be eligible.
The Importance of Early Detection
Early detection offers the best chance for long-term survival, which is why the Prostate Specific Antigen (PSA) blood test combined with a brief exam (DRE or Digital Rectal Exam) has become a standard in early detection. An abnormality does not necessarily mean cancer but can alert healthcare providers that additional tests, such as a prostate biopsy, may need to be considered. A prostate biopsy showing cancer cells is the only way to definitively diagnose prostate cancer.
It is important to weigh the risks and benefits of being screened before making an individual decision. You should have a conversation with your primary doctor or healthcare provider who can assist you with this decision.
Follow-Up Care
Screening results are sent within 3 weeks and personalized recommendations are provided to the patient based on their PSA and DRE results.
- Patients found to be at high risk thus requiring urgent evaluation are reached out to by our schedulers and offered an appointment with one of our providers.
- Participants at intermediate risk are offered a follow-up visit with our urologic oncology providers or encouraged to follow up with their private urologist or primary care provider at their earliest convenience.
- Low-risk patients are invited to return to our screening events in two years.
Ultimately, participants who are diagnosed with prostate cancer have access to our multidisciplinary team of experts from Urologic Oncology, Radiation Oncology, and Medical Oncology for appropriate diagnosis, staging, and treatment as indicated in accordance with current NCCN and AUA guidelines.
Our Team
Massimiliano Spaliviero, MD
Medical Director of Prostate Cancer Program
Howard Adler, MD
Prostate Care Expert
Shannen Harbourne, RN, BSN, MS, OCN
Cancer Program Nurse Navigator
631-216-8299
Elizabeth Schriener
Senior Administrative Assistant
631-216-9181